Inspire Medical Systems Inc (INSP) Clearly Signals Buy-Into the Stock: Don’t ignore the signals

With 0.61 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.52 million shares. The 52-week range on INSP shows that it touched its highest point at $330.00 and its lowest point at $123.27 during that stretch. It currently has a 1-year price target of $252.87. Beta for the stock currently stands at 1.37.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INSP was up-trending over the past week, with a rise of 10.02%, but this was up by 20.93% over a month. Three-month performance surged to 5.56% while six-month performance rose 11.43%. The stock lost -9.99% in the past year, while it has gained 5.58% so far this year. A look at the trailing 12-month EPS for INSP yields -0.74 with Next year EPS estimates of 0.51. For the next quarter, that number is -0.65. This implies an EPS growth rate of 54.86% for this year and 256.59% for next year. EPS is expected to grow by 54.10% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 13.57%.

Float and Shares Shorts:

At present, 29.56 million INSP shares are outstanding with a float of 28.92 million shares on hand for trading. On Mar 15, 2024, short shares totaled 1.87 million, which was 6.16% higher than short shares on Feb 15, 2024. In addition to IINN as the firm’s Inspira Technologies Oxy B.H.N., INAP serves as its INAP.

Institutional Ownership:

Through their ownership of 104.12% of INSP’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for INSP since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.